Literature DB >> 17450268

Is there a place for placebo in management of psychogenic movement disorders?

Erle C H Lim1, Benjamin K C Ong, Raymond C S Seet.   

Abstract

INTRODUCTION: The management of psychogenic movement disorders is fraught with difficulties. Empathy and a non-judgmental manner are essential in dealing with patients, and a neurobiological explanation of the symptoms may help to foster trust, acceptance, understanding and recovery. CLINICAL PICTURE: We report a 17-year-old Chinese girl with psychogenic blepharospasm. Her parents refused psychotherapy and pharmacotherapy. TREATMENT AND OUTCOME: Placebo therapy (with parental consent) was prescribed with favourable results.
CONCLUSION: We examine the ethical considerations for and against placebo therapy, and explore the role of placebo therapy in the management of psychogenic movement disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450268

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  4 in total

1.  The permissible use of placebo.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  J R Soc Med       Date:  2007-09       Impact factor: 5.344

2.  Psychogenic movement disorders.

Authors:  Elizabeth L Peckham; Mark Hallett
Journal:  Neurol Clin       Date:  2009-08       Impact factor: 3.806

3.  Psychogenic movement disorders and motor conversion: a roadmap for collaboration between neurology and psychiatry.

Authors:  Sarah M Kranick; Tristan Gorrindo; Mark Hallett
Journal:  Psychosomatics       Date:  2011 Mar-Apr       Impact factor: 2.386

4.  Recognizing uncommon presentations of psychogenic (functional) movement disorders.

Authors:  José Fidel Baizabal-Carvallo; Robert Fekete
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.